Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C16H13FN2S |
| Molecular Weight | 284.351 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CC1=C(N2CCN=C2S1)C3=C4C=CC=C(F)C4=CC=C3
InChI
InChIKey=LURRPUOCHOPDKB-UHFFFAOYSA-N
InChI=1S/C16H13FN2S/c1-10-15(19-9-8-18-16(19)20-10)13-6-2-5-12-11(13)4-3-7-14(12)17/h2-7H,8-9H2,1H3
| Molecular Formula | C16H13FN2S |
| Molecular Weight | 284.351 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Wed Apr 02 19:52:44 GMT 2025
by
admin
on
Wed Apr 02 19:52:44 GMT 2025
|
| Record UNII |
B27VXE4GHR
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Preferred Name | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
B27VXE4GHR
Created by
admin on Wed Apr 02 19:52:44 GMT 2025 , Edited by admin on Wed Apr 02 19:52:44 GMT 2025
|
PRIMARY | |||
|
57856915
Created by
admin on Wed Apr 02 19:52:44 GMT 2025 , Edited by admin on Wed Apr 02 19:52:44 GMT 2025
|
PRIMARY | |||
|
904960-74-3
Created by
admin on Wed Apr 02 19:52:44 GMT 2025 , Edited by admin on Wed Apr 02 19:52:44 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
TARGET -> AGONIST |
|
||
|
TARGET -> INHIBITOR |
|
||
|
TARGET -> INHIBITOR |
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
ACTIVE MOIETY |
Developed for the treatment of obesity.
|
